Navigation Links
STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
Date:1/15/2008


PARIS, January 15 /PRNewswire-FirstCall/ --

(EURO Millions) 2007 2006 07/06

% % %

Sales Sales Change

Southern Europe(1) 31.99 74.3 27.97 74.7 14

Other EU Countries (2) 9.66 22.4 8.22 22.0 17

Other Markets 1.40 3.3 1.27 3.3 10

SLIT 34.55 80.3 28.75 76.8 20

SCIT 7.12 16.5 6.86 18.3 4

Other Products 1.38 3.2 1.85 4.9 (25)

Total Q4 Sales 43.05 100.0 37.46 100.0 15

Southern Europe (1) 109.15 74.2 93.68 74.0 17

Other EU Countries (2) 32.49 22.1 28.00 22.1 16

Other Markets 5.42 3.7 4.87 3.9 11

FY Sales 147.06 100.0 126.55 100.0 16

SLIT 116.43 79.2 96.30 76.1 21

SCIT 24.90 16.9 24.09 19.0 3

Other Products 5.73 3.9 6.16 4.9 (7)

FY Cumulated Sales 147.06 100.0 126.55 100.0 16

(1) Portugal, Spain, France, Italy, Greece; (2) including Switzerland

Sales growth and financial position

2007 4th quarter sales registered a further 15% growth in all markets. 2007 full-year growth was 16%, driven by the strength of the sublingual route desensitisation segment (SLIT), which grew 21%. The significant increase in the number of new patients, in particular in France and Germany, and growing sales excluding subsidiaries were the main growth drivers.

2007 results, should exceed those of 2006 (EBIT of EUR 23 million), in spite of
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
2. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
3. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
4. SAFC Hitech(TM) Plans Further Expansion Into Asia
5. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
6. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
7. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
10. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
11. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...30, 2009 An international team of applied scienti...ch have demonstrated compact, multibeam, and multi...of the light spectrum (infrared). By contrast, typ...ined wavelength. The innovative multibeam lasers h...e chemical sensing pollution monitoring, optical w...
(Date:11/30/2009)..., Nov. 30 Acuo Technologies, devel... software, data migration tools and services, toda...Clinics for a new Vendor Neutral Archive (VNA), pr... Allina network of hospitals, clinics and affiliat...cuo Technologies DICOM Services Grid(TM) Software....
(Date:11/30/2009)...ov. 30 Novavax, Inc. (Na...nounced today that the company will be presenting ...December 2, 2009 at 12:30 pm local time at The New...verview of the company,s business strategy, resear...s. A link to the live audio only presentation can...
(Date:11/30/2009)...vember 30 Biopharmaceutical compan...ients have been enrolled in its,multinational regi...s,designed to show reduction in transplant related...eneic stem cell transplantation with a mismatched,...ligible for an allogeneic,stem cell transplantatio...
Breaking Biology Technology:Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2
...6 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX:...ulatory agency has granted,marketing approval for ...the first Asian approval of Aridol," said Pharmaxi...a is an important base from which,to launch and gr...ion,asthma sufferers and yet only 160,000 bronchia...
...ar energy cheaper and more efficient is the aim of...lifornia, Davis, and Q1 NanoSystems. The universit...., have agreed on terms for exclusive licensing of...stemming from inventions both on and off campus. ,...facture of very thin, very small wires, films and ...
.... 16 Gen-Probe Incorporated,(Nasdaq: GPRO ) anno...th,quarter and full year 2007 financial results on... p.m. Eastern Time (ET). The announcement will be,...ed by Henry L. Nordhoff,chairman, president and ch...ice president, finance, and chief financial office...
Other Biology Technology:Pharmaxis' Aridol Gains First Asian Approval 2Solar energy technology licensed 2Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call 2
(Date:11/30/2009)...scientists from The Forsyth Institute, the Univers...Wadsworth Center, have used state-of-the-art techn...reponema pallidum, the bacterium which causes syph... the bacteria can now be shown in three dimensions...en and reveals previously unknown features, which ...
(Date:11/30/2009)...ov. 30, 2009) Scientists and engineers from two o...ergy will come together Dec. 7 with leading acade... pumping blood. , Much like moving oil through a...ody. Both systems need clean, well-functioning pi...sion, to function efficiently. Both industries als...
(Date:11/30/2009)...temperatures continue to rise scientists are prese...ow species respond and adapt. In a paper published...sco Rodriguez-Trelles and Dr Miguel Rodriguez asse...rming of approximately 0.6˚C has already affe... facing ecologists and evolutionary biologists is ...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3How can scientists measure evolutionary responses to climate change? 2GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 1GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 2GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 3New IVF Guidelines Aim to Reduce Multiple Births 59861 1New IVF Guidelines Aim to Reduce Multiple Births 59861 2Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 1Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 2Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 3Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 4Lactose Intolerance Rates May Be Significantly Lower Than Previously Believed 59859 5
...Using robotics to manipulate the brain,s perceptio...ers have deepened our understanding of the importa...ntrol of speech. The findings are reported by Sazz...appear in the October 10th issue of the journal Cu... speak, our ability to effectively produce words i...
...When nerve cells excite muscle fibers to flex, get...ht place can mean the difference between feats of ...roteins that have been shown to be major players i...g a flash-freeze physical-fixation technique that ... in neuromuscular synapses. The technique was used...
...In one of the first national studies on guidelines...e in hospitals, researchers from the Indiana Unive...e, Inc. and the Richard Roudebush Veterans Adminis...follow national guidelines on controlling antibiot... , In a study published in the October issue of In...
Other Biology News:Sensory feedback during speech: The brain attunes to more than just sound 2Fast-freeze snapshot yields new picture of nerve-muscle junction 2Controlling antibiotics and antibiotic resistance in hospitals 2
RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
FastStart High Fidelity PCR System, dNTPack (Not available in US) from Roche Applied Science
Biolase Core Kit from Bioline
...eic acids ,The GC-RICH PCR System, a blend of T...owers through templates that are difficult or impo... blends of polymerases. The enhanced processivity ...ution combine to deliver superior performance esp...
Biology Products: